Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
about
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesManagement of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC).Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes.Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingComparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.The clonal origins of leukemic progression of myelodysplasia.Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS PatientsTargeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.Splicing Factor Mutations in Cancer.Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.
P2860
Q28387115-8A0AD03B-EF17-4B55-9AE4-429A0220D878Q28392451-69496A17-93A1-4DAC-A61C-9DE573F1CF82Q30235355-6B2A068E-C73B-446A-BBC9-29CABDFBB266Q30399669-DFB9DF57-BE19-4D82-A008-EA8AD0A263E4Q33573681-E3495851-BF2A-448B-8BB3-F3C1AFBBB337Q34047259-02587C91-E74C-46DB-8FAC-04A6878A8823Q34748960-10D6C607-A03D-423F-B19C-7F34B5E2E671Q36635154-19666B85-7BA0-4F55-8352-BF9401E16CC9Q36642726-F6DE0379-E070-453E-A947-F2492C78AA52Q38406756-E48582E7-EAFD-41CF-955D-CE3E68A53ADAQ38606945-EB2BC397-137E-46E1-B29D-B0163007D438Q40957638-2E30E106-AE7A-4779-B7BA-C9315E4CD846Q47235355-780A09D4-8EAC-4AD9-B668-5CAC40886187Q48102067-E5044601-27B3-4A2E-A4C1-8FB13DE4D60DQ50803287-5C1124B1-704A-45B5-8004-BB5514E0A594Q55064219-DCE201EF-F037-4E9B-A578-030D39F92EEE
P2860
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@ast
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@en
type
label
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@ast
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@en
prefLabel
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@ast
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@en
P2860
P1433
P1476
Clinical and genetic predictors of prognosis in myelodysplastic syndromes.
@en
P2093
Rafael Bejar
P2860
P304
P356
10.3324/HAEMATOL.2013.085217
P577
2014-06-01T00:00:00Z